Association of microRNA 146 with middle ear hyperplasia in pediatric otitis media

Tina L Samuels1, Justin Yan1, Pawjai Khampang1

  • 1Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.

Abstract

Insights

MicroRNA 146 (miR-146) expression is elevated in middle ear tissues of otitis media patients. This suggests miR-146 plays a role in the inflammatory processes of otitis media.

Area of Science:

  • Immunology
  • Molecular Biology
  • Otolaryngology

Background:

  • Toll-like receptor (TLR) signaling is crucial in otitis media (OM) pathogenesis.
  • MicroRNA 146 (miR-146) is known to regulate inflammation via negative feedback of TLR signaling in various tissues.
  • The role of miR-146 in otitis media remains unexplored.

Purpose of the Study:

  • To investigate the expression and role of miR-146 in human otitis media.
  • To determine if miR-146 is differentially expressed in middle ear tissues of OM patients compared to controls.

Main Methods:

  • Human middle ear epithelial cells were stimulated with pro-inflammatory cytokines in vitro.
  • Middle ear biopsies from patients with otitis media (effusion and recurrent) and controls were analyzed.
  • Quantitative PCR (qPCR) was used to measure miR-146a, miR-146b, and their target gene (IRAK1, TRAF6) expression.
  • Epithelial thickness was measured in biopsy cryosections.

Main Results:

  • Pro-inflammatory cytokines induced miR-146 expression in middle ear epithelial cells.
  • miR-146a and miR-146b expression were significantly elevated in middle ear biopsies from OM patients.
  • Elevated miR-146 expression correlated with increased middle ear epithelial thickness.
  • A trend towards inverse correlation between miR-146 and TRAF6 expression was observed.

Conclusions:

  • This study is the first to examine miRNA expression in a clinical population with otitis media.
  • Findings suggest that miR-146 plays a significant role in the pathogenesis of otitis media.
  • miR-146 may serve as a potential biomarker or therapeutic target for otitis media.